All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

pipeline-prospector-insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

VIVEbiotech

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

SPAIN Spain

Post An Enquiry

IFT Annual Expo

Participation Not Confirmed

Update your events

VIVEbiotech Collaborates with Xyphos Biosciences for Clinical Development Support Of Convertible CAR-T™ Cell Therapy

Contact the Supplier

Lead Product(s): Lentiviral vectors,convertible CAR-T cells

Therapeutic Area: Oncology Product Name: Undisclosed

Highest Development Status: Undisclosed Product Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Xyphos Biosciences

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration June 04, 2020

Details:

The agreement covers VIVEbiotech long-term supplying lentiviral vectors for Xyphos’ upcoming clinical trial of its lead convertibleCAR-T™ program. This involves VIVEbiotech manufacturing lentiviral vectors for both preclinical and clinical phases.